BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 16802343)

  • 1. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.
    Brentano F; Schorr O; Ospelt C; Stanczyk J; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2007 Sep; 56(9):2829-39. PubMed ID: 17763446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis.
    Timmer TC; Baltus B; Vondenhoff M; Huizinga TW; Tak PP; Verweij CL; Mebius RE; van der Pouw Kraan TC
    Arthritis Rheum; 2007 Aug; 56(8):2492-502. PubMed ID: 17665400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
    Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
    Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
    J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.
    Ikeuchi H; Kuroiwa T; Hiramatsu N; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Arthritis Rheum; 2005 Apr; 52(4):1037-46. PubMed ID: 15818686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
    Murphy EP; McEvoy A; Conneely OM; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2001 Apr; 44(4):782-93. PubMed ID: 11315917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
    Yokota A; Narazaki M; Shima Y; Murata N; Tanaka T; Suemura M; Yoshizaki K; Fujiwara H; Tsuyuguchi I; Kishimoto T
    J Rheumatol; 2001 Sep; 28(9):1952-9. PubMed ID: 11550959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.
    Redlich K; Kiener HP; Schett G; Tohidast-Akrad M; Selzer E; Radda I; Stummvoll GH; Steiner CW; Gröger M; Bitzan P; Zenz P; Smolen JS; Steiner G
    Arthritis Rheum; 2001 Feb; 44(2):266-74. PubMed ID: 11229456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.
    Antoniv TT; Ivashkiv LB
    Arthritis Rheum; 2006 Sep; 54(9):2711-21. PubMed ID: 16947381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
    Cho ML; Jung YO; Moon YM; Min SY; Yoon CH; Lee SH; Park SH; Cho CS; Jue DM; Kim HY
    Immunol Lett; 2006 Mar; 103(2):159-66. PubMed ID: 16368150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.